Eli Schwartz

4.7k total citations
93 papers, 2.8k citations indexed

About

Eli Schwartz is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Parasitology. According to data from OpenAlex, Eli Schwartz has authored 93 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Public Health, Environmental and Occupational Health, 42 papers in Infectious Diseases and 10 papers in Parasitology. Recurrent topics in Eli Schwartz's work include Mosquito-borne diseases and control (52 papers), Malaria Research and Control (40 papers) and Travel-related health issues (34 papers). Eli Schwartz is often cited by papers focused on Mosquito-borne diseases and control (52 papers), Malaria Research and Control (40 papers) and Travel-related health issues (34 papers). Eli Schwartz collaborates with scholars based in Israel, United States and Canada. Eli Schwartz's co-authors include Annelies Wilder‐Smith, Yaniv Lustig, Yechezkel Sidi, Ella Mendelson, Frank von Sonnenburg, Kevin C. Kain, Eyal Meltzer, Joseph Torresi, Patricia Schlagenhauf and Jay S. Keystone and has published in prestigious journals such as New England Journal of Medicine, Nature Medicine and PLoS ONE.

In The Last Decade

Eli Schwartz

89 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eli Schwartz Israel 28 2.3k 1.4k 393 295 290 93 2.8k
Phyllis E. Kozarsky United States 23 1.7k 0.8× 896 0.6× 370 0.9× 281 1.0× 458 1.6× 50 2.4k
Perry F. Smith United States 22 1.3k 0.6× 1.6k 1.1× 179 0.5× 547 1.9× 191 0.7× 38 2.5k
Mammen P. Mammen Thailand 29 2.4k 1.1× 2.2k 1.5× 228 0.6× 270 0.9× 437 1.5× 46 3.1k
Usa Thisyakorn Thailand 28 1.5k 0.6× 1.5k 1.0× 157 0.4× 662 2.2× 84 0.3× 157 2.5k
Rogelio López‐Vélez Spain 26 1.8k 0.8× 446 0.3× 591 1.5× 958 3.2× 226 0.8× 49 2.5k
Basu Dev Pandey Nepal 26 916 0.4× 1.4k 1.0× 288 0.7× 397 1.3× 137 0.5× 106 2.1k
Stéphane Jauréguiberry France 24 1.5k 0.7× 1.3k 0.9× 530 1.3× 348 1.2× 58 0.2× 84 2.5k
Rivaldo Venâncio da Cunha Brazil 27 1.5k 0.7× 1.2k 0.8× 181 0.5× 637 2.2× 80 0.3× 119 2.3k
Andrea K. Boggild Canada 25 1.1k 0.5× 667 0.5× 442 1.1× 364 1.2× 121 0.4× 121 2.0k
Federico Gobbi Italy 30 1.1k 0.5× 1.1k 0.8× 1.4k 3.5× 448 1.5× 81 0.3× 162 3.1k

Countries citing papers authored by Eli Schwartz

Since Specialization
Citations

This map shows the geographic impact of Eli Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Schwartz more than expected).

Fields of papers citing papers by Eli Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eli Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Schwartz. The network helps show where Eli Schwartz may publish in the future.

Co-authorship network of co-authors of Eli Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Eli Schwartz. A scholar is included among the top collaborators of Eli Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eli Schwartz. Eli Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yelin, Dana, Ian A. Harris, Dafna Yahav, et al.. (2025). Performance of ChatGPT-4o in the diagnostic workup of fever among returning travellers requiring hospitalization: a validation study. Journal of Travel Medicine. 32(4).
2.
Campos, Túlio de Lima, Victoria Indenbaum, Le Thi Hoi, et al.. (2025). Circulating lncRNAs as biomarkers for severe dengue using a machine learning approach. Journal of Infection. 90(4). 106471–106471.
3.
Ashwin, Helen, Jovana Sádlová, Barbora Vojtková, et al.. (2024). Safety and reactogenicity of a controlled human infection model of sand fly-transmitted cutaneous leishmaniasis. Nature Medicine. 30(11). 3150–3162. 5 indexed citations
4.
Solomon, Michal, Ayelet Ollech, Aviv Barzilai, et al.. (2024). Comparison of Intralesional Sodium Stibogluconate versus Intralesional Meglumine Antimoniate for the Treatment of Leishmania major Cutaneous Leishmaniasis. Acta Dermato Venereologica. 104. adv35089–adv35089. 2 indexed citations
5.
Lustig, Yaniv, et al.. (2023). The Role of NS1 Protein in the Diagnosis of Flavivirus Infections. Viruses. 15(2). 572–572. 26 indexed citations
6.
Meltzer, Eyal, et al.. (2023). Comparison of clinical and laboratory parameters of primary vs secondary dengue fever in travellers. Journal of Travel Medicine. 30(7). 4 indexed citations
7.
Breynaert, Annelies, Tess De Bruyne, Corneliu Petru Popescu, et al.. (2022). Can Biomarkers of Oxidative Stress in Serum Predict Disease Severity in West Nile Virus Infection? A Pilot Study. Tropical Medicine and Infectious Disease. 7(9). 207–207. 1 indexed citations
8.
Gautret, Philippe, Kristina M Angelo, Hilmir Ásgeirsson, et al.. (2018). Rabies post-exposure prophylaxis started during or after travel: A GeoSentinel analysis. PLoS neglected tropical diseases. 12(11). e0006951–e0006951. 30 indexed citations
9.
10.
Lachish, Tamar, et al.. (2014). Artemether-Lumefantrine Compared to Atovaquone-Proguanil as a Treatment for Uncomplicated Plasmodium falciparum Malaria in Travelers. American Journal of Tropical Medicine and Hygiene. 92(1). 13–17. 10 indexed citations
11.
Schwartz, Eli. (2012). PROPHYLAXIS OF MALARIA. Mediterranean Journal of Hematology and Infectious Diseases. 4(1). e2012045–e2012045. 15 indexed citations
12.
Neuberger, Ami, et al.. (2012). Infectious Diseases Seen in a Primary Care Clinic in Leogane, Haiti. American Journal of Tropical Medicine and Hygiene. 86(1). 11–15. 18 indexed citations
13.
Kivity, Shaye, Eyal Meltzer, Hanna Bin, & Eli Schwartz. (2011). Protracted Rheumatic Manifestations in Travelers. JCR Journal of Clinical Rheumatology. 17(2). 55–58. 5 indexed citations
14.
Solomon, Michal, Shmuel Benenson, Sharon Baum, & Eli Schwartz. (2011). Tropical Skin Infections Among Israeli Travelers. American Journal of Tropical Medicine and Hygiene. 85(5). 868–872. 15 indexed citations
15.
Meltzer, Eyal, et al.. (2010). [The profile of Israeli travelers to developing countries: perspectives of a travel clinic].. PubMed. 149(9). 559–62, 621. 7 indexed citations
16.
Boggild, Andrea K., Francesco Castelli, Philippe Gautret, et al.. (2010). Vaccine preventable diseases in returned international travelers: Results from the GeoSentinel Surveillance Network. Vaccine. 28(46). 7389–7395. 86 indexed citations
17.
Baird, J. Kevin, Eli Schwartz, & Stephen L. Hoffman. (2007). Prevention and treatment of vivax malaria. Current Infectious Disease Reports. 9(1). 39–46. 39 indexed citations
18.
Schwartz, Eli & Hanan Gur. (2006). Dermatobia hominis Myiasis: An Emerging Disease among Travelers to the Amazon Basin of Bolivia. Journal of Travel Medicine. 9(2). 97–99. 17 indexed citations
19.
Segal, Gad, et al.. (2006). Epidemiology of Travel-Related Hospitalization. Journal of Travel Medicine. 12(3). 136–141. 65 indexed citations
20.
Schwartz, Eli, Fernando Mileguir, Zehava Grossman, & Ella Mendelson. (2000). Evaluation of ELISA-based sero-diagnosis of dengue fever in travelers. Journal of Clinical Virology. 19(3). 169–173. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Phyllis E. Kozarsky Breakdown of academic impact, for papers by Perry F. Smith Breakdown of academic impact, for papers by Mammen P. Mammen Breakdown of academic impact, for papers by Usa Thisyakorn Breakdown of academic impact, for papers by Rogelio López‐Vélez Breakdown of academic impact, for papers by Basu Dev Pandey Breakdown of academic impact, for papers by Stéphane Jauréguiberry Breakdown of academic impact, for papers by Rivaldo Venâncio da Cunha Breakdown of academic impact, for papers by Andrea K. Boggild Breakdown of academic impact, for papers by Federico Gobbi
Rankless by CCL
2026